141 related articles for article (PubMed ID: 2519014)
1. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
[No Abstract] [Full Text] [Related]
2. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.
Kuttler B; Dunger A; Volk HD; Diamantstein T; Hahn HJ
Diabetologia; 1991 Feb; 34(2):74-7. PubMed ID: 2065851
[TBL] [Abstract][Full Text] [Related]
3. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
[TBL] [Abstract][Full Text] [Related]
4. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
[No Abstract] [Full Text] [Related]
5. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
[TBL] [Abstract][Full Text] [Related]
6. Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy.
Hahn HJ; Gerdes J; Lucke S; Liepe L; Kauert C; Volk HD; Wacker HH; Brocke S; Stein H; Diamantstein T
Eur J Immunol; 1988 Dec; 18(12):2037-42. PubMed ID: 3065088
[TBL] [Abstract][Full Text] [Related]
7. In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products.
Boitard C; Michie S; Serrurier P; Butcher GW; Larkins AP; McDevitt HO
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6627-31. PubMed ID: 3901005
[TBL] [Abstract][Full Text] [Related]
8. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
[No Abstract] [Full Text] [Related]
9. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
[No Abstract] [Full Text] [Related]
11. Interleukin 2 receptor-targeted therapy in islet transplantation research.
Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
[No Abstract] [Full Text] [Related]
12. Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen.
Jun HS; Yoon JW
Adv Exp Med Biol; 1994; 347():207-20. PubMed ID: 7976732
[TBL] [Abstract][Full Text] [Related]
13. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
[No Abstract] [Full Text] [Related]
14. Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody.
Jacobson JD; Markmann JF; Brayman KL; Barker CF; Naji A
Diabetes; 1988 Jun; 37(6):838-41. PubMed ID: 3133259
[TBL] [Abstract][Full Text] [Related]
15. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cyclosporine protection against spontaneous diabetes mellitus in the BB/W or rat.
Baquerizo H; Leone J; Pukel C; Wood P; Rabinovitch A
J Autoimmun; 1989 Apr; 2(2):133-50. PubMed ID: 2669795
[TBL] [Abstract][Full Text] [Related]
18. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors.
Hehmke B; Schröder D; Klöting I; Kohnert KD
J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
Kuttler B; Rösing K; Hahn HJ
Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
[No Abstract] [Full Text] [Related]
20. Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.
Brayman KL; Nakai I; Field J; Lloveras JJ; Farney A; Najarian JS; Sutherland DE
Transplant Proc; 1993 Feb; 25(1 Pt 1):284-5. PubMed ID: 8438301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
